Polyunsaturated fatty acids, lung function, and health-related quality of life in patients with chronic obstructive pulmonary disease
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Dietary polyunsaturated fatty acids (PUFA) are thought to modify systemic inflammation. The present study aimed to evaluate the relationship between PUFA intake, lung function, and health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD). Methods: In this study, we used the dataset of 6th Korea National Health and Nutrition Examination Survey, in which, a total of 22,948 individuals including 573 participants with a high probability of developing COPD were enrolled. Participants with missing data for the investigated variables were excluded. Linear regression analyses were used to evaluate the association between PUFA intake (omega-3 [N3], omega-6 [N6], and total) with lung function, and HRQoL. HRQoL was determined according to the European Quality of Life-5 Dimensions (EQ-5D). Subgroup analysis of older patients was performed. Age, sex, body mass index, smoking, alcohol, education, residence, total calorie intake, and predicted FEV1% were adjusted in all analyses. Results: Although lung function was not associated with PUFA intake, EQ-5D index was remarkably associated with N3, N6, and total PUFA intake in a dose-dependent manner. This association was more pronounced in elderly COPD patients. Mean levels of N3, N6, and total PUFA intake were significantly higher in patients having better HRQoL with respect to mobility, self-care, and usual activities. Conclusion: Our results suggest that N3, N6, and total PUFA intake are associated with HRQoL in COPD patients. This association may be attributed to mobility, self-care, and usual activities. Further longitudinal study is required to clarify this relationship.
Abstract
Background: Dietary polyunsaturated fatty acids (PUFA) are thought to modify systemic inflammation. The present study aimed to evaluate the relationship between PUFA intake, lung function, and health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD). Methods: In this study, we used the dataset of 6th Korea National Health and Nutrition Examination Survey, in which, a total of 22,948 individuals including 573 participants with a high probability of developing COPD were enrolled. Participants with missing data for the investigated variables were excluded. Linear regression analyses were used to evaluate the association between PUFA intake (omega-3 [N3], omega-6 [N6], and total) with lung function, and HRQoL. HRQoL was determined according to the European Quality of Life-5 Dimensions (EQ-5D). Subgroup analysis of older patients was performed. Age, sex, body mass index, smoking, alcohol, education, residence, total calorie intake, and predicted FEV1% were adjusted in all analyses. Results: Although lung function was not associated with PUFA intake, EQ-5D index was remarkably associated with N3, N6, and total PUFA intake in a dose-dependent manner. This association was more pronounced in elderly COPD patients. Mean levels of N3, N6, and total PUFA intake were significantly higher in patients having better HRQoL with respect to mobility, self-care, and usual activities. Conclusion: Our results suggest that N3, N6, and total PUFA intake are associated with HRQoL in COPD patients. This association may be attributed to mobility, self-care, and usual activities. Further longitudinal study is required to clarify this relationship.
참고문헌 (30)
- Viegi G, "Definition, epidemiology and natural history of COPD", Eur Respir J, 30, pp.993~1013 (2007)
- Zhu B, "Disease burden of COPD in China : a systematic review", Int J Chron Obstruct Pulmon Dis, 13, pp.1353~1364 (2018)
- 김창환, "Direct and Indirect Costs of Chronic Obstructive Pulmonary Disease in Korea", Tuberculosis and Respiratory Diseases, 82(1), pp.27~34 (2019), 대한결핵및호흡기학회
- Barnes PJ, "Inflammatory mechanisms in patients with chronic obstructive pulmonary disease", J Allergy Clin Immunol, 138, pp.16~27 (2016)
- MacNee W, "Pathogenesis of chronic obstructive pulmonary disease", Proc Am Thorac Soc, 2, pp.258~266 (2005)
- Agusti A, "Persistent systemic inflammation is associated with poor clinical outcomes in COPD : a novel phenotype", PLoS One, 7, pp.e37483~ (2012)
- Kim V, "What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement", Eur Respir J, 52, pp.1801261~ (2018)
- Buckley CD, "Proresolving lipid mediators and mechanisms in the resolution of acute inflammation", Immunity, 40, pp.315~327 (2014)
- Broekhuizen R, "Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease", Thorax, 60, pp.376~382 (2005)
- Lemoine S CM, "Omega-3 fatty acid intake and prevalent respiratory symptoms among U.S. adults with COPD", BMC Pulm Med, 19, pp.97~ (2019)
- Kweon S, "Data resource profile : the Korea National Health and Nutrition Examination Survey(KNHANES)", Int J Epidemiol, 43, pp.69~77 (2014)
- Miller MR, "Standardisation of spirometry", Eur Respir J, 26, pp.319~338 (2005)
- Centers for Disease Control and Prevention (CDC), "Vital signs: nonsmokers' exposure to secondhand smoke. United States, 1999-2008", MMWR Morb Mortal Wkly Rep, 59, pp.1141~1146 (2010)
- Nolan CM, "The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference", Thorax, 71, pp.493~500 (2016)
- EQ-5D Korean valuation study using time trade off method, "Nam H", Korea Centers for Disease Control and Prevention, ~ (2007)
- Karvetti RL, "Validity of the 24-hour dietary recall", J Am Diet Assoc, 85, pp.1437~1442 (1985)
- 서미혜, "2018 Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea", Journal of Obesity & Metabolic Syndrome, 28(1), pp.40~45 (2019), 대한비만학회[DOI]
- Singh D, "Triple therapy in chronic obstructive pulmonary disease", Am J Respir Crit Care Med, 196, pp.1082~1083 (2017)
- Hawthorne G, "The Assessment of Quality of Life(AQoL)instrument : a psychometric measure of health-related quality of life", Qual Life Res, 8, pp.209~224 (1999)
- Esquinas C, "Correlation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary disease", Qual Life Res, 29, pp.607~617 (2020)
- Pickard AS, "Use of a preference-based measure of health(EQ-5D)in COPD and asthma", Respir Med, 102, pp.519~536 (2008)
- Cote CG, "The 6-min walk distance, peak oxygen uptake, and mortality in COPD", Chest, 132, pp.1778~1785 (2007)
- Singh D, "Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019", Eur Respir J, 53, pp.1900164~ (2019)
- Charoenwoodhipong P, "Dietary omega polyunsaturated fatty acid intake and patient-reported outcomes in systemic lupus erythematosus : the Michigan Lupus Epidemiology and Surveillance Program", Arthritis Care Res(Hoboken), 72, pp.874~881 (2020)
- Behboudi-Gandevani S, "The effect of omega 3 fatty acid supplementation on premenstrual syndrome and health-related quality of life : a randomized clinical trial", J Psychosom Obstet Gynaecol, 39, pp.266~272 (2018)
- Moeinzadeh F, "Effects of omega-3 fatty acid supplementation on serum biomarkers, inflammatory agents, and quality of life of patients on hemodialysis", Iran J Kidney Dis, 10, pp.381~387 (2016)
- Croasdell A, "Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages", Am J Physiol Lung Cell Mol Physiol, 309, pp.L888~L901 (2015)
- Baylin A, "Arachidonic acid in adipose tissue is associated with nonfatal acute myocardial infarction in the central valley of Costa Rica", J Nutr, 134, pp.3095~3099 (2004)
- Kaikkonen JE, "High serum n6 fatty acid proportion is associated with lowered LDL oxidation and inflammation : the Cardiovascular Risk in Young Finns Study", Free Radic Res, 48, pp.420~426 (2014)
- Noguchi H, "Limited effect of omega-3 fatty acids on the quality of life in survivors of traumatic injury: a randomized, placebo-controlled trial", Prostaglandins Leukot Essent Fatty Acids, 127, pp.1~5 (2017)